How Red Light Therapy Works on Mitochondria

Red and near-infrared light, typically in the 600 to 900 nanometer range, interact with a specific protein inside your mitochondria called cytochrome c oxidase. This protein sits near the end of the chain that mitochondria use to produce ATP, the molecule your cells burn as fuel. When photons at the right wavelengths hit cytochrome c oxidase, they appear to kick that protein into a higher gear, and a sequence of downstream effects follows that researchers are still working to fully map out.

Cytochrome C Oxidase as the Light Absorber

Mitochondria are often described as cellular power plants, and the comparison is apt enough for this purpose: they take in nutrients and oxygen and convert them into ATP. The last step of that conversion process depends on cytochrome c oxidase (often abbreviated CCO), which sits in what is called complex IV of the mitochondrial respiratory chain. CCO has a particular chemical feature that matters here: it contains copper and iron centers that absorb light in the red and near-infrared spectrum. When photons at roughly 600 to 900 nanometers reach CCO, the protein absorbs them much the way chlorophyll absorbs sunlight in a leaf.

One leading hypothesis for what happens next involves nitric oxide. Under normal conditions, nitric oxide can bind to CCO and slow it down, like a gentle brake on the respiratory chain. The idea is that red and near-infrared light knocks nitric oxide loose from CCO, releasing that brake and allowing the enzyme to process oxygen more efficiently. This would restore or boost the flow of electrons through the chain and raise the electrical charge across the inner mitochondrial membrane, a charge that directly drives ATP production.¹

That said, this model is not universally accepted. When researchers isolated CCO in a test tube and exposed it to red and near-infrared wavelengths, the enzyme’s oxygen consumption did not change significantly. Even when they added a nitric oxide donor to inhibit CCO, the light did not relieve that inhibition.² The result raises a real question: does the light work directly on CCO in the way the dominant theory proposes, or does something more complex happen inside an intact, living cell that a purified enzyme in a dish cannot replicate? Most researchers still consider CCO the primary light absorber, but the precise chain of events between photon absorption and measurable biological change remains an active area of investigation.

From Light Absorption to More ATP

Whatever the exact trigger, cells exposed to red and near-infrared light consistently produce more ATP. In muscle cells treated with light-emitting diodes at 660 nanometers, researchers found a clear time curve: mitochondrial membrane potential and ATP levels both peaked between three and six hours after treatment, with a strong correlation between the two measurements. By 24 hours the boost was fading, and a reading taken just five minutes after treatment showed very little change, suggesting the effect takes time to build and then gradually dissipates.³

A separate line of research proposes an additional mechanism that has nothing to do with CCO directly. ATP synthase, the molecular motor that actually assembles ATP molecules, spins inside a watery environment. One group found that 670-nanometer laser light reduced the viscosity of interfacial water near hydrophilic surfaces by roughly 72 percent. If a similar effect occurs around the nanoscale rotary motor of ATP synthase, the reduced drag could let it spin more freely and produce ATP more efficiently.⁴ This is a more speculative proposal, but it offers an intriguing complementary explanation for why ATP goes up even if the CCO story turns out to be incomplete.

How a Brief Burst of Stress Triggers Protective Signaling

The ATP boost is only part of the story. When mitochondria ramp up their activity under red light, they also produce a short-lived burst of reactive oxygen species, the same molecules often discussed as harmful byproducts of metabolism.⁵ At the low levels generated by photobiomodulation, though, these molecules act less like toxins and more like alarm signals. They flip switches on redox-sensitive pathways inside the cell.

One of those switches is NF-kB, a transcription factor that regulates genes involved in inflammation and immune response. In mouse embryonic fibroblasts, low-level laser therapy activated NF-kB through mitochondrial reactive oxygen species production. The researchers noted something interesting: NF-kB activation is typically pro-inflammatory, yet red light therapy is widely reported to reduce inflammation. One explanation is that the initial, brief NF-kB activation triggers a productive stress response that eventually leads to lower NF-kB activity at later time points, when the therapeutic effects are measured.⁶

The other critical pathway involves a protein called Nrf2, which acts as a master regulator of antioxidant defenses. In skin cells exposed to an inflammatory trigger, both red and near-infrared light reduced the expression of pro-inflammatory signaling molecules like TNF-α, IL-6, and IL-8 while boosting Nrf2 activation. When the researchers removed Nrf2 from the equation, the anti-inflammatory effect of light disappeared, confirming that Nrf2 is not just along for the ride but is essential to how the light calms inflammation.⁷ In a separate study on immune cells treated with 630-nanometer LED light, the same pattern held: Nrf2 went up, NF-kB activity went down, and inflammation decreased along with excess reactive oxygen species.⁸

So the sequence looks roughly like this: light hits CCO, mitochondria produce more ATP and a brief pulse of reactive oxygen species, those molecules activate redox-sensitive transcription factors, and those transcription factors turn on genes that fight inflammation, build antioxidant defenses, and support cell survival. The initial stress is what primes the protective response.

Why the Dose Window Is Narrow

If a small dose of light boosts mitochondrial function and triggers protective signaling, you might assume that more light would be better. It is not. Red light therapy follows what researchers call a biphasic dose response: low doses stimulate and repair tissue, while higher doses lose that benefit or actively cause harm.⁹

The cellular data illustrate this clearly. In one study on muscle cells, the peak response for viability and ATP came at a dose of about 5 joules per square centimeter under near-infrared light, with a moderate rise in reactive oxygen species.¹⁰ In skin fibroblasts irradiated with a 636-nanometer laser, ATP production was optimal up to 15 joules per square centimeter but dropped significantly at 20 and 25, with the authors noting that excessive oxidation is not congenial for cell survival. The 825-nanometer laser produced about twice as much ATP as the 636-nanometer laser at similar doses, but it showed the same sharp decline past 15 joules per square centimeter.¹¹

The mechanism behind this curve maps back to the reactive oxygen species story. At low doses, the brief ROS burst acts as a signaling event. At high doses, the flood of ROS overwhelms the cell’s antioxidant defenses and starts damaging the very mitochondria you were trying to help. The practical takeaway is that more time under a red light panel or a higher-powered device does not translate to more benefit. There is a real window, and overshooting it can be counterproductive.

Getting Light Where It Needs to Go

For any of these mitochondrial effects to happen, photons actually have to reach the tissue you are targeting. Skin and superficial muscle absorb red and near-infrared light reasonably well, which is why applications for wound healing, skin rejuvenation, and surface-level muscle recovery have the strongest practical footing. But as tissue gets thicker or denser, penetration drops fast.

A review of penetration studies across species found dramatic variation. In small rodents, red and near-infrared light at 630 to 810 nanometers penetrated 10 to 70 percent through the skull depending on the mouse strain. In rats with scalp and skull in the way, penetration ranged from 10 to 40 percent. In pigs, which have tissue thicknesses closer to humans, penetration through scalp and skull dropped to about 0.11 percent. In humans, the range was 0.2 to 10 percent, varying with wavelength, light source, tissue thickness, and the spot on the head being measured.¹²

These numbers matter because a lot of the most exciting research on photobiomodulation involves the brain, and translating results from mice to humans is not straightforward. A mouse skull is paper-thin; a human skull is centimeters of bone sheathed in scalp. Near-infrared wavelengths around 800 to 850 nanometers generally penetrate deeper than visible red light around 630 to 660 nanometers, which is one reason near-infrared gets more attention for deep-tissue targets. But even at optimal wavelengths, the fraction of light reaching the human brain through the skull is tiny compared to what reaches a skin cell directly under the LED.

Muscles, Exercise, and Recovery

Skeletal muscle is one of the best-studied targets for red light therapy, partly because muscle tissue is accessible and partly because athletes are willing to try anything that shaves seconds off recovery. Both pre-exercise and post-exercise light treatments have been reported to improve performance, reduce inflammation and oxidative stress in muscle biopsies, and even increase muscle mass gained after training.¹³

At the cellular level, the connection to mitochondria is direct. In injured rat muscle, low-level laser therapy significantly increased the activity of complexes I, II, III, and IV of the mitochondrial respiratory chain compared to injured muscle that received no treatment.¹⁴ That means the light is not just nudging one protein; it appears to ramp up the entire electron transport chain, which is consistent with the idea that relieving a bottleneck at complex IV (where CCO sits) allows the upstream complexes to work more efficiently too.

More recently, researchers found that red light at a dose of 4 joules per square centimeter promoted the expression of key muscle-building transcription factors and boosted myotube formation, mitochondrial metabolism, and mitochondrial biogenesis in lab-cultured muscle precursor cells without harming cell viability.¹⁵ That last point, mitochondrial biogenesis, is worth lingering on: the light is not only making existing mitochondria work harder but may be encouraging the cell to build more of them.

Skin, Collagen, and Wound Repair

Skin cells sit right where the light lands, so they get a full dose with minimal penetration loss. In human dermal fibroblasts and skin explants, a combination of red plus near-infrared light increased the gene expression of collagen types I and III as well as elastin, and it boosted the actual synthesis of procollagen and elastin proteins. ATP production also rose in the treated fibroblasts.¹⁶ The collagen and elastin production is downstream of the mitochondrial boost: more ATP means more energy available for the protein-assembly machinery of the cell.

Red light therapy can also activate CCO to promote wound healing more broadly.¹⁷ The signaling cascade described earlier, where brief reactive oxygen species bursts activate Nrf2 and resolve inflammation, likely plays a role here as well. Wound healing is an energy-intensive process that requires inflammation to be tightly controlled: enough to fight infection, not so much that it stalls tissue repair. The dual effect of photobiomodulation, boosting ATP while activating anti-inflammatory gene networks, is a good fit for that balance.

The Brain and Neurological Research

Despite the penetration challenges, brain-focused photobiomodulation is one of the most active research frontiers. The proposed mechanism is the same as elsewhere: light activates CCO, raises ATP synthesis, and triggers calcium signaling through light-sensitive ion channels, which in turn activates transcription factors and gene expression that enhance neuronal metabolic capacity, reduce oxidative stress, dampen inflammation, and support the growth of new neurons and synapses.¹⁸

In an animal study modeling oxygen deprivation, transcranial red light treatment rescued mitochondrial respiration in the brain. When the light was applied after the hypoxic event, it normalized respiration related to ATP production and membrane polarization, though treatment delayed by 24 hours was less effective than earlier intervention.¹⁹ Researchers have also used broadband near-infrared spectroscopy to non-invasively measure changes in the oxidation state of CCO in the living retina after 670-nanometer light exposure, providing some of the most direct evidence that these mitochondrial shifts can be monitored in real time in vivo.²⁰

The retina is a special case because it is neural tissue that can be reached by light without going through bone. For deeper brain structures, the penetration issue described above is real and unsolved. Some researchers are exploring intranasal delivery or higher-powered transcranial devices, but translating the dramatic results seen in mice to meaningful clinical effects in humans remains a major open question. The biology at the mitochondrial level is consistent across tissues; the engineering challenge is getting enough photons to the target.

Red Versus Near-Infrared and Device Differences

Consumer devices typically offer wavelengths in two clusters: visible red around 630 to 660 nanometers and near-infrared around 810 to 850 nanometers. Both are absorbed by CCO, but they behave differently in tissue. Visible red is absorbed more strongly near the surface, making it well-suited for skin conditions and shallow wounds. Near-infrared penetrates deeper, making it a better candidate for joint, muscle, and neurological applications. Many panels combine both wavelengths, and some of the collagen and elastin research specifically used a red-plus-near-infrared combination to target both superficial and deeper skin layers simultaneously.¹⁶

Whether the light comes from a laser or an LED also matters less than you might think at the cellular level. Both can deliver photons at the right wavelengths; the key differences are power density, beam divergence, and how the dose accumulates across the treatment area. LEDs spread light over a wider area at lower intensity, while lasers concentrate it. For most consumer and clinical applications, LEDs have largely replaced lasers because they cover more tissue at once and carry a lower risk of thermal injury. The critical variable is total energy delivered per unit area, measured in joules per square centimeter, not the light source itself.

What Remains Genuinely Uncertain

The field of photobiomodulation has a reproducibility problem that deserves honest acknowledgment. The isolated-enzyme study that found no effect of red and near-infrared light on CCO activity or nitric oxide displacement is not an outlier to be brushed aside; it challenges the mechanistic story that most of the field relies on.² It is possible that the effect requires an intact cellular environment, membrane context, or secondary chromophores that a purified enzyme assay strips away. But until that gap is closed with definitive experiments, the mechanism remains a well-supported hypothesis rather than a settled fact.

Dosimetry is another area where confidence outpaces evidence. The biphasic response is well documented in cell culture, but translating a dose in joules per square centimeter from a petri dish to a living human is complicated by skin pigmentation, fat thickness, blood flow, and the angle of the device. Two people using the same panel for the same duration could be delivering meaningfully different doses to the target tissue. Most clinical trials report the dose at the skin surface, not at the mitochondria, which makes it hard to compare results across studies or to give precise recommendations.

There is also an open question about cancer cells. The same study that found a biphasic response in healthy muscle cells tested human lung adenocarcinoma cells and observed distinct patterns of viability and ATP response, raising the concern that red light could theoretically stimulate the metabolism of malignant cells in ways that would not be helpful.¹⁰ This does not mean red light panels cause cancer, but it does mean that anyone with an active malignancy should discuss photobiomodulation with their oncologist rather than assuming that boosting mitochondrial function is universally benign.